Search inquiry: <.>II=ЕУ12/2017/39/1<.> |
Total number of found documents : 29
Shown documents from 1 till 20 |
|
1.
| Alternative direction of inhibition of malignant properties in tumor cells in vitro and in vivo by gene therapy with INF-beta gene in recombinant baculovirus vector/O. Lykhova [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90
|
2.
| CD150/SLAMF1 as a new potential target for anti-tumor therapy/S. P. Sidorenko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.90-91
|
3.
| CD150/SLAMF1 antigen in molecular pathobiology of chronic lymphocytic leukemia/I. Gordiienko [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.91-92
|
4.
| Biological characteristics of tumor cells at the different stages of EMT upon exposure to anticancer drugs and cytokines/N. Bezdieniezhnych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89-90
|
5.
| Materials of international vactrain/ 3-rd Swedish-Ukrainian conference on cancer diseases, January 16-17, 2017, Stockholm, Sweden // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-93
|
6.
| Endoplasmic reticulum stress as a key factor of genome reprogramming in cancer cells/O. O. Ratushna [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.88-89
|
7.
| The adaptor protein Ruk/CIN85 paradoxically enhances EMT of triple negative mouse breast adenocarcinoma 4T1 cells/I. Horak [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.89
|
8.
| Brieieva O. Genotoxic sensitivity to 4-hydroxyestradiol in peripheral blood lymphocytes of endometrial cancer patients/O. Brieieva, I. Nesina, L. Buchynska // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.93
|
9.
| Kyiv, May 11-12, 2017 Workshop with international participation. New trends in cancer research and innovative tumor vaccines // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.94
|
10.
| International scientific conference "Normal and and cancer stem cells: discovery, diagnosis and therapy", October 5-6, 2017, Kyiv, Ukraine // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.95
|
11.
| Mankovska O. Identification of novel molecular and genetic markers for early detection and prognosis of epithelial tumors/O. Mankovska, V. Kashuba // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.93
|
12.
| Borikun T. Changes in expression of miRNA-122, -200b, and -320a as prognostic biomarkers for breast cancer/T. Borikun, N. Lukianova, V. Chekhun // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92
|
13.
| The MRPS 18-2 protein as a putative marker of carcinogenesis/M. Mints [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92
|
14.
| High expression levels of MRPS 18-2 and presence of the RB protein are required for the maintenance of stem cell phenotype/M. Mushtag [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.92-93
|
15.
| Trichilemmal cystis in metastatic melanoma/I. Savarese [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.86-87
|
16.
| Parthenolide reduces gene transcription of prosurvival mediators in U937 cells/S. Mohammadi [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.30-35
|
17.
| Anti-histone H1 IgGs prossess proliferative activity towards human T-leukemia CEM cells/Yu. Kit [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.36-41
|
18.
| Anticancer effect and immunologic response to xenogeneic embryonic proteins in mice bearing Ehrlich solid carcinoma/T. V. Symchych [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.42-48
|
19.
| Artemisinin modulating effect on human breast cancer cell lines with different sensitivity to cytostatics/V. F. Chekhun [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.25-29
|
20.
| Circulating tumor cells in breast cancer/N. V. Cherdyntseva [et al.] // Experimental Oncology. -К., 2017. т.Том 39,N N 1.-С.2-11
|
|
|
|
Books
Standard
Home page
Video-instruction
